Literature DB >> 20028650

[Advances in adults' gliomas biology, imaging and treatment].

F Ducray1, G Dutertre, D Ricard, E Gontier, A Idbaih, C Massard.   

Abstract

A better understanding of gliomas biology is now leading to a combined histo-molecular classification of these tumors. In anaplastic gliomas ongoing studies depend on 1p/19q codeletion status and in glioblastomas on MGMT methylation status. Advanced brain tumor imaging elicits a better identification of gliomas evolutive potential of. In low-grade gliomas, the importance of maximal resection and the role of chemotherapy are being increasingly recognized. In anaplastic gliomas, phase III studies have clarified the respective roles of chemotherapy and radiotherapy. In glioblastomas concomitant chemoradiotherapy is the standard. Most targeted therapies, namely anti-EGFR therapies have failed to demonstrate efficacy but anti-angiogenics are promising. The aim of this review is to discuss the main advances in adults' gliomas biology, imaging and treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20028650     DOI: 10.1684/bdc.2009.1019

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  4 in total

1.  Fluorescence lifetime spectroscopy for guided therapy of brain tumors.

Authors:  Pramod V Butte; Adam N Mamelak; Miriam Nuno; Serguei I Bannykh; Keith L Black; Laura Marcu
Journal:  Neuroimage       Date:  2010-11-03       Impact factor: 6.556

2.  Identification of a novel population in high-grade oligodendroglial tumors not deleted on 1p/19q using array CGH.

Authors:  Matthieu Talagas; Pascale Marcorelles; Arnaud Uguen; Sylvia Redon; Isabelle Quintin-Roué; Sebastian Costa; Claude Férec; Frédéric Morel; Phong Dam Hieu; Marc De Braekeleer
Journal:  J Neurooncol       Date:  2012-07-24       Impact factor: 4.130

3.  Long-term follow-up in adult patients with low-grade glioma (WHO II) postoperatively irradiated. Analysis of prognostic factors.

Authors:  Anna Mucha-Małecka; Bogdan Gliński; Marcin Hetnał; Magdalena Jarosz; Jacek Urbański; Beata Frączek-Błachut; Paweł Dymek; Krzysztof Małecki; Agnieszka Chrostowska
Journal:  Rep Pract Oncol Radiother       Date:  2012-02-10

4.  Proton MR Spectroscopy and Diffusion MR Imaging Monitoring to Predict Tumor Response to Interstitial Photodynamic Therapy for Glioblastoma.

Authors:  Magali Toussaint; Sophie Pinel; Florent Auger; Nicolas Durieux; Magalie Thomassin; Eloise Thomas; Albert Moussaron; Dominique Meng; François Plénat; Marine Amouroux; Thierry Bastogne; Céline Frochot; Olivier Tillement; François Lux; Muriel Barberi-Heyob
Journal:  Theranostics       Date:  2017-01-05       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.